Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bronwen E Shaw

Showing results (1-10 of 202) with videos related to

Pageof 21
Sort By:
Current Hematologic Malignancy Reports|January 15, 2019
Graft Versus Host Disease Clinical Trials: Is it Time for Patients Centered Outcomes to Be the Primary Objective?Bronwen E Shaw
Blood|June 19, 2010
First do no harmBronwen E Shaw
Blood Advances|January 4, 2018
Related haploidentical donors are a better choice than matched unrelated donors: CounterpointBronwen E Shaw
Blood Cells, Molecules & Diseases|October 30, 2007
Immunogenetic factors in donors and patients that affect the outcome of hematopoietic stem cell transplantationAlejandro Madrigal, Bronwen E Shaw
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 16, 2012
Allogeneic transplantation: when is a mismatch better than a match?Bronwen E Shaw, Anthony Nolan
Blood|July 2, 2017
HLA-DP in unrelated hematopoietic cell transplantation revisited: challenges and opportunitiesKatharina Fleischhauer, Bronwen E Shaw
Current Opinion in Immunology|April 30, 2026
Optimal donor selection for transplant to reduce GVHD risk and augment graft-versus-malignancy efficacyBrian C Shaffer, Bronwen E Shaw
Expert Review of Hematology|July 12, 2012
'First do no harm': where do we stand on unrelated hematopoietic cell donor safety?Robert N Lown, Bronwen E Shaw
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2019
Importance of Assessing Patient-Reported Outcomes With Salvage Autologous Transplantation in Relapsed Multiple MyelomaBronwen E Shaw, Anita D'Souza, Stephanie J Lee
Bone Marrow Transplantation|May 26, 2018
Prevention of relapse after allogeneic hematopoietic cell transplantation by donor and cell source selectionKatharina Fleischhauer, Katharine C Hsu, Bronwen E Shaw
Pageof 21

Showing results (1-10 of 202) with videos related to

Sort By:
Pageof 21
Current Hematologic Malignancy Reports|January 15, 2019
Graft Versus Host Disease Clinical Trials: Is it Time for Patients Centered Outcomes to Be the Primary Objective?Bronwen E Shaw
Blood|June 19, 2010
First do no harmBronwen E Shaw
Blood Advances|January 4, 2018
Related haploidentical donors are a better choice than matched unrelated donors: CounterpointBronwen E Shaw
Blood Cells, Molecules & Diseases|October 30, 2007
Immunogenetic factors in donors and patients that affect the outcome of hematopoietic stem cell transplantationAlejandro Madrigal, Bronwen E Shaw
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 16, 2012
Allogeneic transplantation: when is a mismatch better than a match?Bronwen E Shaw, Anthony Nolan
Blood|July 2, 2017
HLA-DP in unrelated hematopoietic cell transplantation revisited: challenges and opportunitiesKatharina Fleischhauer, Bronwen E Shaw
Current Opinion in Immunology|April 30, 2026
Optimal donor selection for transplant to reduce GVHD risk and augment graft-versus-malignancy efficacyBrian C Shaffer, Bronwen E Shaw
Expert Review of Hematology|July 12, 2012
'First do no harm': where do we stand on unrelated hematopoietic cell donor safety?Robert N Lown, Bronwen E Shaw
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2019
Importance of Assessing Patient-Reported Outcomes With Salvage Autologous Transplantation in Relapsed Multiple MyelomaBronwen E Shaw, Anita D'Souza, Stephanie J Lee
Bone Marrow Transplantation|May 26, 2018
Prevention of relapse after allogeneic hematopoietic cell transplantation by donor and cell source selectionKatharina Fleischhauer, Katharine C Hsu, Bronwen E Shaw
Pageof 21